Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Food Effect of SR419 in Healthy Subjects
NCT04705077Phase 1Completed
- Sponsor
- Shanghai SIMR Biotechnology Co., Ltd.
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sr419 in Peripheral neuropathic pain (2 arms), sponsored by Shanghai SIMR Biotechnology Co., Ltd. Primary endpoints: Peak Plasma Concentration, Time to Peak Plasma Concentration and 4 more. Started Feb 2021; status: completed.
02
Drugs
sr419
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT04705077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705077.